Anesthesia Endotracheal Tube Market to Surpass US$ 228.7 Million by 2026

With the adoption of new technologies and advancement of health care facilities, surgery of vital organs such as lungs has become easy. During this surgeries, anesthesia endotracheal tubes are used by surgeons to sedate the patient by delivering oxygen, xenon, and anesthetic agents such as sevoflurane & isoflurane. Thus, makes this market more attractive which enables the critical surgery more efficient. Additionally, it consider as a substitute for other drug delivery systems as they are also used to administer other medications such as salbutamol, ipratropium, and lidocaine.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2025

The global anesthesia endotracheal tubes market was valued at US$ 134.2 million in 2017, and is expected to witness a CAGR of 6.1% over the forecast period (2018 – 2026).

Increasing number of surgeries is expected to drive growth of the anesthesia endotracheal tubes market

Administration of anesthesia through endotracheal tubes is used during different surgical procedures which are conducted to manage various diseases including gastrointestinal diseases, cardiovascular diseases, spinal abnormalities, urological disorders, orthopedic deformities, and brain tumors. Thus, the increasing volume of surgical procedures across the globe is likely to drive the overall growth of the anesthesia endotracheal tubes market in the forecast period.

The significant growth in the number of surgeries, especially in the European countries will help in the growth of the anesthesia endotracheal tubes market in this region. For example, the amount of laparoscopic colostomy surgeries tripled in Spain and doubled in Slovenia between 2008 and 2014. Different types of surgeries performed in various ambulatory surgical centers include hernia procedure, cervix and uterus removal, transurethral excision, lens and cataract, and hysterectomy which also attributed to the overall market growth.

Furthermore, increase in aging population who suffer from asthma, pulmonary disease and chronic obstructive pulmonary disease is expected to favor the anesthesia endotracheal tubes market. According to world ageing population reports in the U.S. between 2015 and 2030, the number of people in the world aged 60 years or over is projected to grow by 56 per cent, from 901 million to 1.4 billion, and by 2050, the global population of older persons is projected to more than double its size in 2015, reaching nearly 2.1 billion.

Nevertheless, lack of proper health care facilities especially in the underdeveloped countries as well as in remote areas, product recalls and presence of few anesthetists and certified nurse per capita of population are likely to inhibit the growth of the anesthesia endotracheal tubes market.

For instance in January 2014, Medtronic’s product- NIM TriVantage electromyography (EMG) Endotracheal Tube got terminated form the market by FDA, due to cuff leakage in the intraoperative cuff deflation which then requires re-inflation or replacement of the deflated tube in order to ensure the continued ventilation of the patient.

Anesthesia Endotracheal Tubes Market- Regional Analysis

Regional segmentation of the global anesthesia endotracheal tubes market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America hold the major share due to higher per capita income and technological advancement. Also, rise in health concerns among the people formed a major factor for rise in minimally invasive procedures in the U.S. According to American Society of Plastic Surgeons (ASPS), around 15.9 million surgical and minimally-invasive cosmetic procedures performed in the U.S. in 2015 which showed a 2% increase over 2014.

Asia Pacific is expected to witness fastest growth in the global anesthesia endotracheal tubes market due to increasing patient pool and growing medical tourism for various surgeries in the region. For instance, according to Directorate-General of Commercial Intelligence and Statistics of India, in 2015-2016, hospitals in India recorded 460,000 international patients.

Moreover, according to Indian Medical Travel Journal, the top five hospital namely, Apollo, Fortis, Narayana Health, Manipal Hospital, and Max Healthcare generated revenue of around US$ 155 million by international patients.

Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/2025

Anesthesia Endotracheal Tubes Market- Competitive Landscape

Manufacturers are focusing on providing innovative products by providing new material coatings to prevent from Ventilator associated Pneumonia (VAP), a common hospital-spread infections in people who are intubated and mechanically ventilated.

CR Bard’s The AGENTO I.C. silver-coated endotracheal tube (ETT) is a scientifically proven, ventilator-associated pneumonia (VAP) preventive device for patients at risk of intubation for 24 hours or longer that minimizes user dependence.

Key players operating in the anesthesia endotracheal tubes market include Medtronic Plc, General Electric Company, C. R. Bard, Inc., ConvaTec Group plc, Smith Medical, Inc., KindWell Medical Equipment Co.,Ltd, Royax, Fuji Systems Corp., Teleflex Incorporated., Neurovision Medical Products and Intersurgical GmbH

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.